Ozempic is a once-weekly prescription medicine containing semaglutide, a GLP-1 receptor agonist used primarily to help adults with type 2 diabetes improve blood sugar control.
A Semaglutide is a prescription weight loss therapy in Singapore used to help adults with type 2 diabetes improve glycaemic control, with additional benefits that may include weight loss and cardiovascular risk reduction when appropriate lifestyle measures are followed under medical supervision.
Unlike insulin, this medicine mimics a naturally occurring gut hormone that is released after meals and acts on the brain, pancreas, and gut to help control blood sugar and appetite.
Type 2 diabetes is a chronic metabolic condition characterised by insulin resistance and progressive beta-cell dysfunction. The result is elevated blood glucose, increased cardiometabolic risk, and—if not addressed—complications affecting the eyes, kidneys, nerves, heart and circulation. Managing glucose effectively requires a multi-system approach:
Pancreas and liver: Semaglutide increase glucose-dependent insulin secretion and reduce inappropriate glucagon, smoothing post-meal spikes.
Gastrointestinal tract: They slow gastric emptying, moderating the rate at which glucose enters the bloodstream.
Central nervous system: They enhance satiety signals, often helping patients feel full sooner and reducing caloric intake.
This multi-organ mechanism explains why, in the real world, many patients notice better HbA1c control, reduced weight, and cardiometabolic benefits when treatment is correctly titrated and supported with lifestyle measures. The booklet summarises these patient-relevant benefits explicitly: manages blood sugar to reach HbA1c goals, helps with weight loss, and can help prevent heart disease.
The primary goal is to lower and stabilise blood glucose. Consistent weekly dosing plus dietary and activity support can help many patients move toward target HbA1c. (See the “benefits” summary.)
By acting on satiety pathways and slowing gastric emptying, patients may eat smaller portions with less hunger, supporting weight reduction in those who need it.
Treatment can help prevent heart disease as part of comprehensive care—an important message for patients with co-existing cardiometabolic risks.
Adults with type 2 diabetes who require additional glycaemic control after lifestyle measures and/or other oral agents.
Patients who may benefit from an agent that assists with weight loss alongside glucose control.
Individuals for whom a once-weekly regimen improves adherence compared with daily medications.
Not everyone is suitable. At The Clifford Clinic, we will review medical history, current medications, cardiovascular profile and pancreato-biliary risk before prescribing.
Ozempic works by enhancing glucose-dependent insulin release, reducing inappropriate glucagon, and slowing gastric emptying to smooth post-meal glucose spikes.
Semaglutide enhances insulin secretion only when glucose is elevated, thereby supporting safer physiological control.
Gastric emptying is slowed, which may smooth post-meal glucose excursions.
Appetite regulation in the brain reduces hunger and snacking.
This targeted, glucose-dependent effect differentiates Semaglutide from non-selective appetite suppressants and complements other diabetes medicines mechanistically.
Many patients on Ozempic also notice reduced appetite and smaller portion sizes, which can support weight reduction under medical supervision.
Consists of a simple start–step–stay approach: begin low, increase gradually, and stay at a dose that meets your clinical goals. Specifically:
Start: 0.25 mg once weekly for 4 weeks.
Step: Increase to 0.5 mg once weekly for at least 4 weeks.
Stay: Based on individual needs, remain at 0.5 mg or increase to 1 mg once weekly at your doctor’s direction.
This gradual increase aids tolerability, especially for the gastrointestinal system
Unlike insulin, Ozempic does not replace the body’s insulin directly; it modulates the hormones that influence appetite and glucose handling.
Choose a consistent day each week and take your dose on that day; it does not depend on meals.
Many patients anchor the dose to a weekly routine (e.g., Sunday evening) to build adherence.
If the missed dose is within 5 days, take it as soon as you remember; then return to your normal dosing day.
If more than 5 days have passed, skip the missed dose and take the next dose on your regularly scheduled day.
Do not double the dose to make up for a missed injection.
Doctors typically start Ozempic at a low dose and increase gradually to improve tolerability, especially for gastrointestinal side effects.
This medicine is given subcutaneously (under the skin, not into muscle or vein). Recommended areas: the front of the thighs, abdomen (stomach area), or upper arms. Rotate sites within the chosen area to avoid irritation.
Check the pen and attach a new needle (the guide references a 32G 4-mm needle as the thinnest compatible option for a once-weekly GLP-1 RA).
Check the flow on a new pen by selecting the flow check symbol and pressing the dose button until a drop appears (first use only).
Select your dose using the dial until the counter shows the prescribed amount (e.g., 0.25 mg, 0.5 mg, or 1 mg).
Inject the dose: insert the needle and press-and-hold the dose button until the counter returns to “0,” then slowly count to 6.
Remove the needle and dispose of it safely; replace the pen cap.
Do let us know before starting and during treatment if any of the following apply to you:
Type 1 diabetes
Semaglutide is not indicated for type 1 diabetes or diabetic ketoacidosis. Your doctor will advise appropriate alternatives.
Using insulin or a sulfonylurea (e.g., glipizide, gliclazide, tolbutamide)
Combining these with semaglutide may increase the risk of low blood sugar (hypoglycaemia). Your doctor may adjust doses and teach you how to recognise and treat hypos.
History of pancreatitis (pancreas inflammation)
Report any severe, persistent abdominal pain (with or without vomiting). Your doctor may stop treatment and evaluate for pancreatitis.
Heart, kidney, or liver problems
Dose selection, monitoring, and hydration advice may need to be individualised. Tell your doctor if you notice swelling, sudden weight changes, reduced urine output, or breathlessness.
Thyroid cancer or family history of thyroid cancer
Inform your doctor if you or a family member has had medullary thyroid carcinoma (MTC) or if you have MEN2 (Multiple Endocrine Neoplasia syndrome type 2). Report neck lumps, hoarseness, difficulty swallowing, or shortness of breath.
History of depression or other mood disorders
Tell your clinician if mood changes, low mood, or thoughts of self-harm occur; prompt review is important.
Pregnant, planning pregnancy, or breastfeeding
Semaglutide is not recommended in pregnancy or while breastfeeding. Use effective contraception while on therapy and inform your doctor if you become pregnant or plan to conceive; you may need to stop treatment in advance.
Taking other medicines, supplements, or herbal/traditional remedies
Provide a full list. Some agents can affect blood sugar or gastrointestinal motility. Your doctor will check for interactions and advise on timing (e.g., spacing oral medicines if significant nausea occurs).
The most common side effects with Ozempic are mild nausea, bloating, or diarrhoea, which often settle as the dose is stabilised.
Take the injection once weekly on the same day, exactly as prescribed.
Learn the signs of low blood sugar (sweating, shakiness, hunger, dizziness, confusion) if using with insulin/sulfonylureas; carry a quick source of glucose.
Hydrate well, eat smaller meals, and avoid very rich or spicy foods during dose escalation to reduce nausea.
Do not use if the solution looks cloudy, coloured, or contains particles.
Rotate injection sites (abdomen, thigh, upper arm) and avoid areas that are tender, bruised, scarred, or with stretch marks.
Store and handle the pen as instructed (refrigeration before first use; in-use storage per label).
If you develop unexpected or severe symptoms—especially severe abdominal pain, signs of an allergic reaction, or persistent vomiting—seek medical attention promptly
Most side effects are mild to moderate and improve as your body adjusts, especially during the first few weeks of dose escalation. If symptoms persist or feel severe, contact your clinician.
Nausea, vomiting, bloating, stomach discomfort
Tips: avoid oily or spicy foods, eat small portions at a time, and keep well hydrated.
Diarrhoea
Tips: hydrate regularly (water or oral rehydration), choose bland foods until symptoms settle.
Constipation (less common)
Tips: fluids, fibre, gentle activity; speak to your clinician if persistent.
Bruising, redness, or mild pain at the injection site
Tips: rotate the injection site every week (abdomen, thigh, upper arm), do not reuse needles, and avoid areas that are tender, scarred, or with stretch marks.
Feeling tired, headache
Runny nose, nose or throat irritation
Semaglutide alone has a low risk of hypoglycaemia, but the risk increases if you use insulin or a sulfonylurea. Learn to recognise symptoms:
Ozempic is taken on the same day each week, with or without food, and missed-dose instructions depend on how many days have passed.
Most side effects are mild to moderate and improve as your body adjusts, especially during the first few weeks of dose escalation. If symptoms persist or feel severe, contact your clinician.
Baseline assessment: medical history, co-morbidities, medication review, goals, and safety screening.
Education & training: hands-on pen use, injection sites, rotation, storage, and sharps disposal (as reinforced in the booklet).
Dose titration: start–step–stay schedule with side-effect coaching and dietary guidance.
Review cadence: early follow-ups to assess tolerability, then ongoing reviews focused on HbA1c, weight trajectory, cardiometabolic markers and overall wellbeing.
Long-term plan: agree on duration; discuss deprescribing or transitions as needed, ensuring lifestyle habits carry gains forward.
Because Ozempic slows gastric emptying, clinicians sometimes give special instructions before surgery or procedures requiring sedation.
Take it on the same day weekly and follow the 5-day missed-dose rule if necessary.
Store properly (refrigerated before first use; up to 6 weeks at room temp <30 °C or refrigerated after opening).
Use a new needle for each injection and dispose of sharps safely.
Report side effects early; do not self-adjust the dose.
In summary, a once-weekly semaglutide regimen can be a valuable part of type 2 diabetes care—supporting glucose control, weight management, and cardiometabolic health—when used under careful medical supervision alongside sustainable lifestyle changes.
Always use Ozempic only under medical supervision, and follow your clinic’s instructions and the official patient leaflet for safe storage, injection technique, and follow-up.
Moderate alcohol may be permissible for many patients, but it can increase the risk of hypoglycaemia when combined with other diabetes medicines and may worsen gastric symptoms (nausea, reflux). If you drink, do so with food, avoid binge intake, monitor glucose closely (especially if you use insulin or a sulfonylurea), and discuss limits with your clinician if you have fatty liver disease, pancreatitis history, or hypertriglyceridaemia.
Because semaglutide slows gastric emptying, some anaesthesia teams recommend withholding a dose prior to procedures to reduce aspiration risk during sedation. The plan depends on your operation timing, other medications, and diabetes control. Inform your surgeon/anaesthetist early; your doctor may coordinate peri-procedural glucose monitoring and advise when to resume after you are eating and tolerating fluids.
Semaglutide is not recommended during pregnancy or breastfeeding. Most clinicians advise a washout period before trying to conceive; the exact duration should be confirmed with your doctor based on your dose, clinical profile, and alternative glucose-control plans. Use effective contraception while on therapy and book a pre-conception review to plan a safe transition.
While semaglutide has few classic drug–drug interactions, its effect on gastric emptying can influence the absorption and timing of certain oral medicines (e.g., thyroxine, some antibiotics, extended-release formulations). Your doctor may recommend taking critical medicines at a consistent time unrelated to your injection and watching for efficacy changes. Always share a full list of prescriptions, supplements, and herbal products; some (e.g., berberine, high-dose niacin, gymnema) may affect glucose.
Patients should follow the instructions provided by their doctor. In most cases, a missed dose can be administered within a specific time window or skipped until the next scheduled injection.
Dose adjustments are not always required, but clinicians pay close attention to hydration status and GI tolerability, as prolonged vomiting/diarrhoea can precipitate acute kidney injury or electrolyte imbalance. You may be asked to increase fluids during dose escalations, monitor weight and urine output, and obtain periodic blood tests (renal panel, electrolytes, HbA1c, lipids). Report persistent GI symptoms early to avoid dehydration.
